Parathyromatosis: a rare yet problematic etiology of recurrent and persistent hyperparathyroidism
Abstract Recurrent or persistent hyperparathyroidism is an uncommon yet challenging clinical problem, and parathyromatosis is one of its very rare causes. In this minireview, we review causes of recurrent hyperparathyroidism and all cases of parathyromatosis available in the literature. The clinical...
Gespeichert in:
Veröffentlicht in: | Metabolism, clinical and experimental clinical and experimental, 2012-06, Vol.61 (6), p.762-775 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 775 |
---|---|
container_issue | 6 |
container_start_page | 762 |
container_title | Metabolism, clinical and experimental |
container_volume | 61 |
creator | Hage, Mirella P Salti, Ibrahim El-Hajj Fuleihan, Ghada |
description | Abstract Recurrent or persistent hyperparathyroidism is an uncommon yet challenging clinical problem, and parathyromatosis is one of its very rare causes. In this minireview, we review causes of recurrent hyperparathyroidism and all cases of parathyromatosis available in the literature. The clinical course of a case of parathyromatosis with the longest follow-up (1977-2011) is described. Similar cases reported between 1975 and the present are reviewed and analyzed to characterize the clinical presentation, course, and management of this rare condition. Parathyromatosis, which is benign parathyroid tissue seeding, has been detailed in 35 patients in the English literature. The majority were female subjects, with end-stage renal disease, in their fifth to sixth decade of life. In most cases, the diagnosis was made intraoperatively; and the condition was often refractory to surgery. A calcimimetic agent was used in 5 cases with end-stage renal disease; serum calcium and/or parathyroid hormone levels decreased in 4 subjects, but only one was reported to experience increments in bone density. Medical management combining a calcimimetic with a bisphosphonate may therefore be a preferred alternative. |
doi_str_mv | 10.1016/j.metabol.2011.11.001 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1017620544</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0026049511003659</els_id><sourcerecordid>1017620544</sourcerecordid><originalsourceid>FETCH-LOGICAL-c450t-16b6602f4efd873ca3e47654cdeeb8770afac5aaba2e518f9b8093e2d18125523</originalsourceid><addsrcrecordid>eNqFkluL1DAUgIMo7rj6E5S-CL50PEmbpPXBRRZvsKCgPofT9NTN2DZjkgr996bMrIIvhgPhkO9c-AhjTznsOXD18rCfKGHnx70Azvc5APg9tuOyEmWjAO6zHYBQJdStvGCPYjwAgNaNesguRD68Ec2O4WcMmG7X4CdMPrr4qsAiYKBipVQcg-9Gyi_OFpScH_33tfBDEcguIdCcCpz74kghF6YtvV1zcrxr6XoXp8fswYBjpCfn-5J9e_f26_WH8ubT-4_Xb25KW0tIJVedUiCGmoa-0ZXFimqtZG17oq7RGnBAKxE7FCR5M7RdA21FoucNF1KK6pK9OPXNS_9cKCYzuWhpHHEmv0STrWklQNZ1RuUJtcHHGGgwx-AmDGuGNk6ZgznbNZtdkyPbzXXPziOWbqL-T9Wdzgw8PwMYLY5DwNm6-JeTrdKVVpm7OnGUhfxyFEy0jmZLvctqk-m9--8qr__pYEc3uzz0B60UD34Jc7ZtuInCgPmyfYXtJ3AOUCnZVr8BTzSx2A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1017620544</pqid></control><display><type>article</type><title>Parathyromatosis: a rare yet problematic etiology of recurrent and persistent hyperparathyroidism</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Hage, Mirella P ; Salti, Ibrahim ; El-Hajj Fuleihan, Ghada</creator><creatorcontrib>Hage, Mirella P ; Salti, Ibrahim ; El-Hajj Fuleihan, Ghada</creatorcontrib><description>Abstract Recurrent or persistent hyperparathyroidism is an uncommon yet challenging clinical problem, and parathyromatosis is one of its very rare causes. In this minireview, we review causes of recurrent hyperparathyroidism and all cases of parathyromatosis available in the literature. The clinical course of a case of parathyromatosis with the longest follow-up (1977-2011) is described. Similar cases reported between 1975 and the present are reviewed and analyzed to characterize the clinical presentation, course, and management of this rare condition. Parathyromatosis, which is benign parathyroid tissue seeding, has been detailed in 35 patients in the English literature. The majority were female subjects, with end-stage renal disease, in their fifth to sixth decade of life. In most cases, the diagnosis was made intraoperatively; and the condition was often refractory to surgery. A calcimimetic agent was used in 5 cases with end-stage renal disease; serum calcium and/or parathyroid hormone levels decreased in 4 subjects, but only one was reported to experience increments in bone density. Medical management combining a calcimimetic with a bisphosphonate may therefore be a preferred alternative.</description><identifier>ISSN: 0026-0495</identifier><identifier>EISSN: 1532-8600</identifier><identifier>DOI: 10.1016/j.metabol.2011.11.001</identifier><identifier>PMID: 22221828</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Biological and medical sciences ; Endocrinology & Metabolism ; Endocrinopathies ; Feeding. Feeding behavior ; Fundamental and applied biological sciences. Psychology ; Humans ; Hyperparathyroidism - etiology ; Hyperparathyroidism - surgery ; Medical sciences ; Non tumoral diseases. Target tissue resistance. Benign neoplasms ; Parathyroid Glands - surgery ; Parathyroidectomy ; Parathyroids. Parafollicular cells. Cholecalciferol. Phosphocalcic homeostasis (diseases) ; Recurrence ; Vertebrates: anatomy and physiology, studies on body, several organs or systems</subject><ispartof>Metabolism, clinical and experimental, 2012-06, Vol.61 (6), p.762-775</ispartof><rights>Elsevier Inc.</rights><rights>2012 Elsevier Inc.</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2012 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c450t-16b6602f4efd873ca3e47654cdeeb8770afac5aaba2e518f9b8093e2d18125523</citedby><cites>FETCH-LOGICAL-c450t-16b6602f4efd873ca3e47654cdeeb8770afac5aaba2e518f9b8093e2d18125523</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0026049511003659$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=25967376$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22221828$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hage, Mirella P</creatorcontrib><creatorcontrib>Salti, Ibrahim</creatorcontrib><creatorcontrib>El-Hajj Fuleihan, Ghada</creatorcontrib><title>Parathyromatosis: a rare yet problematic etiology of recurrent and persistent hyperparathyroidism</title><title>Metabolism, clinical and experimental</title><addtitle>Metabolism</addtitle><description>Abstract Recurrent or persistent hyperparathyroidism is an uncommon yet challenging clinical problem, and parathyromatosis is one of its very rare causes. In this minireview, we review causes of recurrent hyperparathyroidism and all cases of parathyromatosis available in the literature. The clinical course of a case of parathyromatosis with the longest follow-up (1977-2011) is described. Similar cases reported between 1975 and the present are reviewed and analyzed to characterize the clinical presentation, course, and management of this rare condition. Parathyromatosis, which is benign parathyroid tissue seeding, has been detailed in 35 patients in the English literature. The majority were female subjects, with end-stage renal disease, in their fifth to sixth decade of life. In most cases, the diagnosis was made intraoperatively; and the condition was often refractory to surgery. A calcimimetic agent was used in 5 cases with end-stage renal disease; serum calcium and/or parathyroid hormone levels decreased in 4 subjects, but only one was reported to experience increments in bone density. Medical management combining a calcimimetic with a bisphosphonate may therefore be a preferred alternative.</description><subject>Biological and medical sciences</subject><subject>Endocrinology & Metabolism</subject><subject>Endocrinopathies</subject><subject>Feeding. Feeding behavior</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Humans</subject><subject>Hyperparathyroidism - etiology</subject><subject>Hyperparathyroidism - surgery</subject><subject>Medical sciences</subject><subject>Non tumoral diseases. Target tissue resistance. Benign neoplasms</subject><subject>Parathyroid Glands - surgery</subject><subject>Parathyroidectomy</subject><subject>Parathyroids. Parafollicular cells. Cholecalciferol. Phosphocalcic homeostasis (diseases)</subject><subject>Recurrence</subject><subject>Vertebrates: anatomy and physiology, studies on body, several organs or systems</subject><issn>0026-0495</issn><issn>1532-8600</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkluL1DAUgIMo7rj6E5S-CL50PEmbpPXBRRZvsKCgPofT9NTN2DZjkgr996bMrIIvhgPhkO9c-AhjTznsOXD18rCfKGHnx70Azvc5APg9tuOyEmWjAO6zHYBQJdStvGCPYjwAgNaNesguRD68Ec2O4WcMmG7X4CdMPrr4qsAiYKBipVQcg-9Gyi_OFpScH_33tfBDEcguIdCcCpz74kghF6YtvV1zcrxr6XoXp8fswYBjpCfn-5J9e_f26_WH8ubT-4_Xb25KW0tIJVedUiCGmoa-0ZXFimqtZG17oq7RGnBAKxE7FCR5M7RdA21FoucNF1KK6pK9OPXNS_9cKCYzuWhpHHEmv0STrWklQNZ1RuUJtcHHGGgwx-AmDGuGNk6ZgznbNZtdkyPbzXXPziOWbqL-T9Wdzgw8PwMYLY5DwNm6-JeTrdKVVpm7OnGUhfxyFEy0jmZLvctqk-m9--8qr__pYEc3uzz0B60UD34Jc7ZtuInCgPmyfYXtJ3AOUCnZVr8BTzSx2A</recordid><startdate>20120601</startdate><enddate>20120601</enddate><creator>Hage, Mirella P</creator><creator>Salti, Ibrahim</creator><creator>El-Hajj Fuleihan, Ghada</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20120601</creationdate><title>Parathyromatosis: a rare yet problematic etiology of recurrent and persistent hyperparathyroidism</title><author>Hage, Mirella P ; Salti, Ibrahim ; El-Hajj Fuleihan, Ghada</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c450t-16b6602f4efd873ca3e47654cdeeb8770afac5aaba2e518f9b8093e2d18125523</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Biological and medical sciences</topic><topic>Endocrinology & Metabolism</topic><topic>Endocrinopathies</topic><topic>Feeding. Feeding behavior</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Humans</topic><topic>Hyperparathyroidism - etiology</topic><topic>Hyperparathyroidism - surgery</topic><topic>Medical sciences</topic><topic>Non tumoral diseases. Target tissue resistance. Benign neoplasms</topic><topic>Parathyroid Glands - surgery</topic><topic>Parathyroidectomy</topic><topic>Parathyroids. Parafollicular cells. Cholecalciferol. Phosphocalcic homeostasis (diseases)</topic><topic>Recurrence</topic><topic>Vertebrates: anatomy and physiology, studies on body, several organs or systems</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hage, Mirella P</creatorcontrib><creatorcontrib>Salti, Ibrahim</creatorcontrib><creatorcontrib>El-Hajj Fuleihan, Ghada</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Metabolism, clinical and experimental</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hage, Mirella P</au><au>Salti, Ibrahim</au><au>El-Hajj Fuleihan, Ghada</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Parathyromatosis: a rare yet problematic etiology of recurrent and persistent hyperparathyroidism</atitle><jtitle>Metabolism, clinical and experimental</jtitle><addtitle>Metabolism</addtitle><date>2012-06-01</date><risdate>2012</risdate><volume>61</volume><issue>6</issue><spage>762</spage><epage>775</epage><pages>762-775</pages><issn>0026-0495</issn><eissn>1532-8600</eissn><abstract>Abstract Recurrent or persistent hyperparathyroidism is an uncommon yet challenging clinical problem, and parathyromatosis is one of its very rare causes. In this minireview, we review causes of recurrent hyperparathyroidism and all cases of parathyromatosis available in the literature. The clinical course of a case of parathyromatosis with the longest follow-up (1977-2011) is described. Similar cases reported between 1975 and the present are reviewed and analyzed to characterize the clinical presentation, course, and management of this rare condition. Parathyromatosis, which is benign parathyroid tissue seeding, has been detailed in 35 patients in the English literature. The majority were female subjects, with end-stage renal disease, in their fifth to sixth decade of life. In most cases, the diagnosis was made intraoperatively; and the condition was often refractory to surgery. A calcimimetic agent was used in 5 cases with end-stage renal disease; serum calcium and/or parathyroid hormone levels decreased in 4 subjects, but only one was reported to experience increments in bone density. Medical management combining a calcimimetic with a bisphosphonate may therefore be a preferred alternative.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>22221828</pmid><doi>10.1016/j.metabol.2011.11.001</doi><tpages>14</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0026-0495 |
ispartof | Metabolism, clinical and experimental, 2012-06, Vol.61 (6), p.762-775 |
issn | 0026-0495 1532-8600 |
language | eng |
recordid | cdi_proquest_miscellaneous_1017620544 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Biological and medical sciences Endocrinology & Metabolism Endocrinopathies Feeding. Feeding behavior Fundamental and applied biological sciences. Psychology Humans Hyperparathyroidism - etiology Hyperparathyroidism - surgery Medical sciences Non tumoral diseases. Target tissue resistance. Benign neoplasms Parathyroid Glands - surgery Parathyroidectomy Parathyroids. Parafollicular cells. Cholecalciferol. Phosphocalcic homeostasis (diseases) Recurrence Vertebrates: anatomy and physiology, studies on body, several organs or systems |
title | Parathyromatosis: a rare yet problematic etiology of recurrent and persistent hyperparathyroidism |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T09%3A45%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Parathyromatosis:%20a%20rare%20yet%20problematic%20etiology%20of%20recurrent%20and%20persistent%20hyperparathyroidism&rft.jtitle=Metabolism,%20clinical%20and%20experimental&rft.au=Hage,%20Mirella%20P&rft.date=2012-06-01&rft.volume=61&rft.issue=6&rft.spage=762&rft.epage=775&rft.pages=762-775&rft.issn=0026-0495&rft.eissn=1532-8600&rft_id=info:doi/10.1016/j.metabol.2011.11.001&rft_dat=%3Cproquest_cross%3E1017620544%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1017620544&rft_id=info:pmid/22221828&rft_els_id=S0026049511003659&rfr_iscdi=true |